Newborn eye ointment, specifically erythromycin, is a standard practice in the United States, given to nearly all newborns to prevent a specific type of eye infection.
What it is
Newborn eye ointment is an antibiotic medication, erythromycin, applied to your baby's eyes shortly after birth. Its primary purpose is to prevent ophthalmia neonatorum, a severe eye infection caused by gonorrhea, which can lead to blindness if untreated. This practice became widespread at a time when screening for sexually transmitted infections (STIs) during pregnancy was not as common as it is today. In most U.S. states, its application is mandated by law.
What the evidence says
The routine application of erythromycin eye ointment is rooted in historical public health efforts. Today, most pregnant individuals are screened for gonorrhea and chlamydia during prenatal care, significantly reducing the risk of transmission. This shift in screening practices has led to different approaches in other countries. For instance, countries like the UK and Sweden do not require routine eye prophylaxis for newborns when the birthing parent's STI screening results are negative. This divergence highlights a conversation point between routine practice and current evidence, especially for those with negative STI screenings.
One consideration with the ointment is its potential side effects on your newborn. It can cause temporary blurred vision for about an hour after application, which might affect your baby's initial ability to focus and engage during the crucial Skin-to-Skin at Birth period, potentially impacting the first feeding and early bonding moments. Understanding these nuances allows you to make an informed decision.
When it's recommended
In the U.S., newborn eye ointment is routinely recommended for all babies immediately after birth. However, it can typically be delayed for at least one hour to support the "golden hour" of uninterrupted skin-to-skin contact and the initiation of breastfeeding. This delay allows for precious early bonding and feeding opportunities without interruption. For those who have had negative STI screenings, discussing the necessity and timing of this intervention with your care provider well in advance is a valuable step. Refusal of the ointment is legally possible in most U.S. states, emphasizing that this is an area where you have choices about your baby's immediate postpartum care, just as you have choices during Non-Pharmacological Labor Comfort.
